EGFR-mutated NSCLC
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations (NCT05241873) | Blueprint Medicines Corporation | 2022-03-04 |
Track EGFR-mutated NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.